Canada: Study Officially Completed

On November 27, 2016, investigators gathered for the formal closeout of our Phase 2 pilot study of MDMA-assisted psychotherapy for PTSD in Vancouver, Canada. Conducted by Clinical Trial Leader Alli Feduccia, …

Canada: Final Participant Completes 12-Month Follow-Up

On October 17, 2016, the sixth and final participant completed their 12-month follow-up interview in our Phase 2 pilot study of MDMA-assisted psychotherapy for PTSD in Vancouver, Canada. All participants …

Canada: Enrollment Concluded

On November 2, 2015, enrollment was concluded in our study of MDMA-assisted psychotherapy for PTSD from sexual assault, violent crime, military service, or any other cause, taking place in Vancouver, Canada. …

Canada: Two More Subjects Treated

On June 26 and July 3, 2015, the fifth and sixth subjects were treated in our ongoing Canadian study of MDMA-assisted psychotherapy for PTSD. The sixth subject was enrolled on June 29. Led by Principal …

Canada: Fifth Subject Enrolled

On June 10, 2015, the fifth subject was enrolled in our ongoing Canadian study of MDMA-assisted psychotherapy for PTSD. Led by Principal Investigator Ingrid Pacey, M.D., in Vancouver, B.C., this Phase …

Canada: Third Subject Treated in Vancouver Study

On March 14, 2015, the third subject received their first experimental treatment in our Canadian study of MDMA-assisted psychotherapy for PTSD. The second subject received their first treatment on Feb …

Canada: First Subject Treated in Vancouver Study

On February 3, 2015, the first subject received their first experimental treatment in our Canadian study of MDMA-assisted psychotherapy for PTSD. The purpose of this small Phase 2 study in up to 12 subjects …

Canada: First Subject Enrolled

On December 3, 2014, the first subject was enrolled in our Canadian study of MDMA-assisted psychotherapy for PTSD, led by Principal Investigator Ingrid Pacey, M.D., in Vancouver, BC. Goals for this study …

Canadian Study: Subject Screening Begins

On September 2, 2014, the first potential subjects were screened for our Canadian study of MDMA-assisted psychotherapy for PTSD. Led by Principal Investigator Ingrid Pacey, M.D., and co-therapists Donna …